Treatment Registry
TR-1002 ActiveRecorded October 2026

Compounded semaglutide

Sold by Framework · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

No comparable monthly price verified at this reading. See dated notes for any advertised starting figures.

Visit Framework

We earn nothing from this link. It opens Framework's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • October 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberNot disclosed
CancellationCancel in the patient portal at least 72 hours before renewal. Processed or shipped orders are generally final. If a prescription is required but not issued, the order is declined and payment refunded.
MembershipNone. “$0 membership fees.”
Consult feeNot disclosed

Recorded from yourframework.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. October 2026 — Semaglutide and tirzepatide are named with an explicit compounded-formulation disclaimer. The generic $25/week starting offer does not establish a molecule-specific price, billing term or device. https://yourframework.com/
  2. 2. October 2026 — Clinician check-ins and dietitian support are included. https://yourframework.com/
  3. 3. October 2026 — Cancellation and clinical-ineligibility refunds: https://yourframework.com/terms-of-service

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-1002
Medication category
compounded semaglutide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Framework — compounded semaglutide (TR-1002). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-1002

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.